Home › Funds › NEXTBio Capital Management LP › ANIX

NEXTBio Capital Management LP position in ANIX

ANIXA BIOSCIENCES · Health Care

NEXTBio Capital Management LP reported holding 175,403 shares of ANIX (ANIXA BIOSCIENCES) in its Q3 2026 13F filing — a position valued at US$5.6M, representing 2.44% of its reported portfolio and ranking #18 among its reported holdings. NEXTBio Capital Management LP first reported this position in Q3 2026.

Latest position (Q3 2026)175.40K sh
Reported value held$5.61M
Portfolio Weight2.44%
First reportedQ3 2026
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How NEXTBio Capital Management LP's ANIX position evolved

NEXTBio Capital Management LP first disclosed a stake in ANIX in Q3 2026 at 175,403 shares (US$5.6M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 175.40K $5.61M New

About ANIX and 13F data

ANIX (ANIXA BIOSCIENCES) is a Health Care company. 36 other funds we track also report a position in ANIX — the largest reported positions include Sanofi (US$63.8M), Vivo Capital, LLC (US$28.1M), Remedium Capital Partners, LLC (US$16.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANIX

All ANIX fund holders →

FAQ

How long has NEXTBio Capital Management LP held ANIX?

NEXTBio Capital Management LP has disclosed ANIX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is NEXTBio Capital Management LP's current position in ANIX?

As of Q3 2026, NEXTBio Capital Management LP holds 175.40K shares of ANIX (ANIXA BIOSCIENCES), valued at $5.61M, representing 2.44% of its reported portfolio and ranking #18.

Has NEXTBio Capital Management LP been buying or selling ANIX?

In the latest 13F filing (Q3 2026), NEXTBio Capital Management LP newly opened its position in ANIX.

Which other funds hold ANIX?

Other major institutional holders of ANIX include Sanofi, Vivo Capital, LLC, Remedium Capital Partners, LLC, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.